Patients carrying a BMPR2 mutation in which PAH manifests at a younger age might have a more severe mutation that not only results in more extensive pulmonary vascular remodelling or impaired right ventricular adaptation at diagnosis, but also results in more rapid progression of the disease process. Here, BMPR2 is linked to pulmonary arterial hypertension.